Literature DB >> 10577925

Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13.

A Toren1, N Amariglio, G Rozenfeld-Granot, A J Simon, F Brok-Simoni, E Pras, G Rechavi.   

Abstract

Fechtner syndrome is an autosomal-dominant variant of Alport syndrome, manifested by nephritis, sensorineural hearing loss, cataract formation, macrothrombocytopenia, and polymorphonuclear inclusion bodies. As opposed to autosomal-recessive and X-linked Alport syndromes, which have been genetically well studied, the genetic basis of Fechtner syndrome remains elusive. We have mapped the disease-causing gene to the long arm of chromosome 22 in an extended Israeli family with Fechtner syndrome plus impaired liver functions and hypercholesterolemia in some individuals. Six markers from chromosome 22q yielded a LOD score >3.00. A maximum two-point LOD score of 7.02 was obtained with the marker D22S283 at a recombination fraction of 0. Recombination analysis placed the disease-causing gene in a 5.5-Mb interval between the markers D22S284 and D22S1167. No collagen genes or genes comprising the basement membrane have been mapped to this region.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577925      PMCID: PMC1288382          DOI: 10.1086/302654

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Hereditary thrombocytopenia, deafness, and renal disease.

Authors:  J D Eckstein; D J Filip; J C Watts
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

2.  Pathologic characteristics of hereditary nephritis.

Authors:  J Churg; R L Sherman
Journal:  Arch Pathol       Date:  1973-06

3.  Identification of a single base insertion in the COL4A5 gene in Alport syndrome.

Authors:  H Nakazato; S Hattori; T Matsuura; Y Koitabashi; F Endo; I Matsuda
Journal:  Kidney Int       Date:  1993-11       Impact factor: 10.612

4.  A splicing mutation in the alpha 5(IV) collagen gene of a family with Alport's syndrome.

Authors:  S Nomura; G Osawa; T Sai; T Harano; K Harano
Journal:  Kidney Int       Date:  1993-05       Impact factor: 10.612

5.  Colocalization of the genes for the alpha 3(IV) and alpha 4(IV) chains of type IV collagen to chromosome 2 bands q35-q37.

Authors:  M Mariyama; K Zheng; T L Yang-Feng; S T Reeders
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

6.  Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).

Authors:  J A Jefferson; H H Lemmink; A E Hughes; C M Hill; H J Smeets; C C Doherty; A P Maxwell
Journal:  Nephrol Dial Transplant       Date:  1997-08       Impact factor: 5.992

7.  Alport's syndrome associated with macrothrombopathic thrombocytopenia.

Authors:  N M Clare; M M Montiel; M D Lifschitz; G A Bannayan
Journal:  Am J Clin Pathol       Date:  1979-07       Impact factor: 2.493

8.  Major rearrangements in the alpha 5(IV) collagen gene in three patients with Alport syndrome.

Authors:  E Boye; D Vetrie; F Flinter; B Buckle; T Pihlajaniemi; E R Hamalainen; J C Myers; M Bobrow; A Harris
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

9.  Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors.

Authors:  J Zhou; T Mochizuki; H Smeets; C Antignac; P Laurila; A de Paepe; K Tryggvason; S T Reeders
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

10.  Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene.

Authors:  C Antignac; J Zhou; M Sanak; P Cochat; B Roussel; G Deschênes; F Gros; B Knebelmann; M C Hors-Cayla; K Tryggvason
Journal:  Kidney Int       Date:  1992-11       Impact factor: 10.612

View more
  4 in total

1.  The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1.

Authors:  J A Martignetti; K E Heath; J Harris; N Bizzaro; A Savoia; C L Balduini; R J Desnick
Journal:  Am J Hum Genet       Date:  2000-03-17       Impact factor: 11.025

2.  Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.

Authors:  K E Heath; A Campos-Barros; A Toren; G Rozenfeld-Granot; L E Carlsson; J Savige; J C Denison; M C Gregory; J G White; D F Barker; A Greinacher; C J Epstein; M J Glucksman; J A Martignetti
Journal:  Am J Hum Genet       Date:  2001-10-04       Impact factor: 11.025

3.  Molecular and genetic basis of inherited nephrotic syndrome.

Authors:  Maddalena Gigante; Matteo Piemontese; Loreto Gesualdo; Achille Iolascon; Filippo Aucella
Journal:  Int J Nephrol       Date:  2011-09-06

4.  Alteration of liver enzymes is a feature of the MYH9-related disease syndrome.

Authors:  Alessandro Pecci; Ginevra Biino; Tiziana Fierro; Valeria Bozzi; Annamaria Mezzasoma; Patrizia Noris; Ugo Ramenghi; Giuseppe Loffredo; Fabrizio Fabris; Stefania Momi; Umberto Magrini; Mario Pirastu; Anna Savoia; Carlo Balduini; Paolo Gresele
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.